September 1, 2014
Drug makers affiliated with the Japan Pharmaceutical Manufacturers Association (JPMA) have finally begun disclosing details of the funding they provided to healthcare professionals and patients’ organizations in FY2013 in accordance with the JPMA’s transparency guidelines. In the vanguard was Pfizer...read more